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The plant defensin NaD1 is a potent antifungal molecule that also targets tumor cells with a high efficiency. We examined the
features of NaD1 that contribute to these two activities by producing a series of chimeras with NaD2, a defensin that has rela-
tively poor activity against fungi and no activity against tumor cells. All plant defensins have a common tertiary structure known
as a cysteine-stabilized-motif which consists of an helix and a triple-stranded -sheet stabilized by four disulfide bonds.
The chimeras were produced by replacing loops 1 to 7, the sequences between each of the conserved cysteine residues on NaD1,
with the corresponding loops fromNaD2. The loop 5 swap replaced the sequence motif (SKILRR) that mediates tight binding
with phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] and is essential for the potent cytotoxic effect of NaD1 on tumor cells.
Consistent with previous reports, there was a strong correlation between PI(4,5)P2 binding and the tumor cell killing activity of
all of the chimeras. However, this correlation did not extend to antifungal activity. Some of the loop swap chimeras were efficient
antifungal molecules, even though they bound poorly to PI(4,5)P2, suggesting that additional mechanisms operate against fungal
cells. Unexpectedly, the loop 1B swap chimera was 10 times more active than NaD1 against filamentous fungi. This led to the
conclusion that defensin loops have evolved as modular components that combine to make antifungal molecules with variable
mechanisms of action and that artificial combinations of loops can increase antifungal activity compared to that of the natural
variants.
Innate immunity peptides have evolved in plants to protectagainst the damaging effects of microbial pathogens, particu-
larly fungi (1). Fungi cause both persistent annual crop losses and
devastating epidemics (2) that are a serious threat to global food
security (3). Plants lack the adaptive immune system of mammals
and instead rely on a suite of antifungal peptides to ward off in-
fection (1). Defensins are a major family of plant antifungal pep-
tides (4, 5), and some members have been studied extensively
because of their potential use in transgenic plants for protection
against fungal disease (6–8).
Plant defensins are small peptides (45 to 54 amino acids) that
are basic and cysteine rich. They have a conserved three-dimen-
sional structure composed of three -strands linked to an -helix
by three disulfide bonds together with a fourth disulfide bond that
links the N- and C-terminal regions and creates a pseudo cyclic
structure (9). Beyond the 8 cysteine residues and a conserved gly-
cine that is required for the structural fold, there is a great deal of
sequence variability across the plant defensin family. This variabil-
ity is displayed in seven loops (loop 1 [L1] to L7) that correspond
to the regions between cysteine residues (Fig. 1) (5). The sequence
diversity explains the wide range of functions that have been re-
ported for plant defensins, including antibacterial and antifungal
activities as well as roles in plant development, sexual reproduc-
tion, and metal tolerance (reviewed in reference 5). Some antifun-
gal defensins display activity against tumor cells but not healthy
mammalian cells (10, 11). However, it remains to be established if
the mechanism of action against fungal and mammalian tumor
cells is the same.
Fungal cell killing by the defensin NaD1 from the ornamental
tobacco Nicotiana alata occurs through a mechanism that in-
volves specific interaction with the fungal cell wall before it passes
through the plasma membrane and enters the fungal cytoplasm.
Once inside the cell, NaD1 rapidly initiates the production of re-
active oxygen species (ROS), permeabilization of the fungal
plasma membrane, and cell death (12–14). The activity against
tumor cell lines is mediated by a specific and high-affinity inter-
action with phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2].
This lipid binding specificity has been described only for the class
II defensins from the Solanaceae among plant defensins and is
largely mediated through the sequence in loop 5 (10, 11, 15). Class
II defensins have a C-terminal propeptide that directs them to the
vacuole, whereas class I defensins lack this sequence and are se-
creted by default from the plant cell (9). Interestingly, even though
human and plant defensins have evolved separately (16), a related
sequence in loop 5 of human -defensin 3 (17) is required for
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PI(4,5)P2 binding and tumor cell killing. The defensins NaD1 and
TPP3 from tomatoes both dimerize and form the cationic grip
which binds two PI(4,5)P2 molecules. The defensin-PI(4,5)P2
dimer then forms oligomers via a different interface (10). The
interaction of NaD1 and TPP3 with PI(4,5)P2 is proposed to lead
to the characteristic blebbing and membrane permeabilization
that occurs when tumor cells are treated with these defensins (10,
11). Indeed, masking of PI(4,5)P2 by intracellular expression of a
pleckstrin homology domain or treatment with neomycin delayed
tumor cell killing by NaD1, supporting the role for PI(4,5)P2
binding in the activity against tumor cells (10, 11). Mutations in
residues that participate in PI(4,5)P2 binding reduced both tumor
and fungal cell killing by these defensins (10, 11).
NaD2 is another defensin produced by N. alata that has weaker
antifungal activity than NaD1 against filamentous fungi and rusts
(18). NaD2 is not a member of the solanaceous class II defensin
family but is a member of the much larger family of class I de-
fensins which are produced by all plant families. Here we report
that unlike NaD1, NaD2 has no activity against tumor cells. We
investigated the role of various sequence components in the lipid
binding, tumor cell killing, and antifungal activities of NaD1 by
swapping the loop regions of NaD1 for corresponding loops from
NaD2. These studies revealed a strong correlation between
PI(4,5)P2 binding and tumor cell killing across all of the chimeric
defensins. This correlation did not extend to the antifungal activ-
ities of the loop swap chimeras, indicating that the role of
PI(4,5)P2 binding is not as crucial in fungal cell killing by these
defensins.
MATERIALS AND METHODS
Strains and vectors. The Fusarium oxysporum f. sp. vasinfectum strain
used in this study was an Australian isolate from cotton (Farming Systems
FIG 1 Loop swap variants of NaD1 and NaD2. (A) Loops are defined as intercysteine sequences (shown here using NaD1 as a model with cysteine residues and
disulfides in gray). The residues that participate in the interaction between NaD1 and PI(4,5)P2 are highlighted in yellow in the NaD1 sequence. L1A (blue)
consists of the first -strand. L1B (red) is the random-coil/turn region joining the strand to the -helix. L2 (brown), L3 (yellow), and L4A (olive) make up the
-helix. L4B (cyan) forms the second -strand. L5 (pink) is a surface loop connecting two -strands, and L6 and L7 (L6&7; green) form the final -strand (PDB
accession number 4AAZ [26]). (B) Sequence alignment of the loop-swapped proteins, which contain a loop of NaD2 in the NaD1 framework. The NaD2 loop
sequences are color coded as described in the legend to panel A. The column on the right indicates the charge of each defensin at pH 7. The white boxes below
the sequences indicate regions that form-strands, and the black box indicates the helical region of NaD1. (C) Sequence and charge at pH 7 of two other proteins
reported to bind PI(4,5)P, TPP3 and HBD3.
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Institute, Department of Primary Industries, Queensland, Australia; a gift
from Wayne O’Neill). Aspergillus niger (strain 5181), Aspergillus flavus
(strain 5310), and Aspergillus parasiticus (strain 4467) spores (a gift from
Dee Carter, University of Sydney) were grown on half-strength potato
dextrose agar (PDA) plates. Candida albicans (strain DAY185) and Cryp-
tococcus neoformans (strain H99; a gift from Dee Carter, University of
Sydney) were grown on 1% yeast extract, 2% peptone, 2% dextrose (YPD)
agar plates and cultured at 30°C in YPD. All experiments with S. cerevisiae
were performed in a strain BY4741 (MATa his30 leu20 met150
ura30) or BY4743 (MATa/ his31/his31 leu20/leu20 LYS2/lys20
met150/MET15 ura30/ura30) background. Deletion strains were re-
trieved from the nonessential knockout (inp51, inp52, lsb6) or
heterozygous essential knockout (STT4/stt4, PIK1/pik1, MSS4/mss4)
collection (Thermo Scientific). Native NaD1 and NaD2 were purified
from Nicotiana alata flowers as described in reference 12. LL37 was pur-
chased from GenScript (Hong Kong).
Cloning and expression of loop swap proteins. Loops in the NaD1
(GenBank accession no. Q8GTM0) defensin were replaced by the corre-
sponding loops from NaD2 (GenBank accession no. KX688721) using
Phusion mutagenesis (New England BioLabs) of an NaD1 construct in the
pHUE expression vector (19). Both loops 1 and 4 were split into two
shorter regions yielding an A and a B chimera for each loop. Loops 6 and
7 were both short and were thus combined when the chimeric proteins
were made. Proteins were expressed in Escherichia coli T7 (New England
BioLabs) according to the manufacturer’s instructions and were purified
using nickel affinity chromatography. The ubiquitin/His tag was removed
using ubiquitin-specific protease 2 at a final concentration of 70 g/ml,
followed by reverse nickel affinity chromatography. Proteins were puri-
fied further by reverse-phase high-performance liquid chromatography
using a Zorbax C8 analytical column (Agilent). Correct folding of loop
swap variants was confirmed by circular dichroism (CD).
Circular dichroism. Stock solutions of each of the proteins were pre-
pared in H2O (0.5 to 1.0 mg/ml) and diluted 1:4 in 10 mM sodium
phosphate buffer, pH 6.8, prior to measurement. CD spectra at wave-
lengths ranging from 185 to 260 nm were recorded on a Jasco J-810 spec-
tropolarimeter at room temperature using quartz cuvettes with a path
length of 1 cm (151 data points per scan; bandwidth, 1.7 nm; response, 1 s;
scan speed, 100 nm/min). The value for the buffer blank was subtracted,
and the spectra were smoothed using the algorithm included in the Jasco
data analysis software and plotted using GraphPad Prism software. Frac-
tional helicity (fH) was calculated as described in reference 20.
Antifungal assays. Antifungal assays were performed with F. oxyspo-
rum, Fusarium graminearum, and Colletotrichum graminicola as described
in reference 12. F. oxysporum and F. graminearum growth was assayed
after 24 h, andC. graminicola growth was assayed after 48 h. Assays withC.
albicans, C. neoformans, and S. cerevisiae were performed as described in
reference 21. The 50% inhibitory concentrations (IC50s) for F. oxysporum
were identified from the growth inhibition curves. The 95% confidence
intervals (CIs) were calculated. Overlapping CIs were assigned the same
letter, and values with different letters were significantly different.
Tumor cell permeabilization assays. Permeabilization of cells from a
human monocytic lymphoma cell line, U937, was monitored using a pro-
pidium iodide (PI) uptake assay as described in reference 10 with some
modifications. Protein at 0, 2.5, 5, 10, or 20 M was incubated with 4
104 cells in RPMI 1640 medium (Thermo) containing 0.1% bovine serum
albumin (Sigma-Aldrich) for 30 min at 37°C, before the addition of PI (Sig-
ma-Aldrich) to a final concentration of 1g/ml. Samples were placed on ice
and analyzed by flow cytometry using a FACSCanto II flow cytometer with
FACSDiva software (v6.1.1; BD Biosciences). Data were analyzed by FlowJo
software (Tree star) by gating cells on the basis of forward and side scatter. Cell
permeabilization was defined by PI fluorescence. Statistical analysis was per-
formed as described above for the antifungal assays.
Permeabilization of liposomes. Liposomes were prepared as outlined
in reference 10. Permeabilization of liposomes was assessed by monitor-
ing the release of entrapped calcein as described in references 22 and 13.
The fluorescence of the released calcein was used as a measure of permea-
bilization and was calculated relative to that of the Triton X-100 (0.1%)-
treated positive control. Statistical analysis was performed as described
above for the antifungal assays.
Fungal membrane permeabilization assays. Membrane permeabili-
zation was monitored using SYTOX green as outlined in reference 13.
Assays for the permeabilization activity of loop swap variants against F.
oxysporum hyphae were performed using test proteins at 10 M.
Lipid binding. Binding of protein to a variety of membrane lipids was
tested using PIP strips (batch numbers KE071312 and KE020212; Echelon
Biosciences, Salt Lake City, UT), as described in the manufacturer’s pro-
tocol and in reference 10. Antibodies to NaD1 and NaD2 were polyclonal
antibodies developed in rabbits.
Yeast survival assays. S. cerevisiae BY4741 cells were grown overnight
at 30°C in YPD. Aliquots of an overnight culture (500 l) were treated
with neomycin (10, 1, 0.1, 0 mM) for 3 h. Cells were washed three times
with half-strength potato dextrose broth (1/2 PDB; BD Difco) and then
diluted in 1/2 PDB to an optical density at 600 nm of 0.2. Cells were treated
with 20 and 10 M NaD1, 30 and 15 M LL37, 50 and 25 M L5, and
water for 1 h at 30°C with shaking. To determine the survival of yeast cells
in each treatment, a 5-fold dilution series of each treatment combination
was plated on YPD agar plates and incubated at 30°C for 2 days. Images of
the plates were taken using a ChemiDoc imager (Bio-Rad) at the epi-
White settings. Data were consistent across three independent biological
experiments.
Accession number. NaD2 has been deposited in GenBank under ac-
cession no. KX688721.
RESULTS
Protein expression and folding. Eight NaD1-NaD2 loop swap
proteins were produced recombinantly in E. coli using the pHUE
expression system. These proteins consisted of an NaD1 backbone
in which each of the loops of NaD1 was replaced with the corre-
sponding loop from NaD2 (Fig. 1). Purified recombinant protein
was analyzed by SDS-PAGE and matrix-assisted laser desorption
ionization mass spectrometry to ensure that the expressed pro-
teins were of the expected size (data not shown). Two of the re-
combinant proteins, L2 and L3, did not express well and were not
included in subsequent experiments. Loops 1 and 4 are the longer
loops in plant defensins and as such were each split across two
chimeric defensins, denoted A and B. Loops 6 and 7 are the short-
est loops in plant defensins (1 and 3 amino acids, respectively) and
were thus combined into a single chimeric defensin. L1A was ex-
pressed at very low levels and was omitted from some experi-
ments. The CD spectra of recombinantly expressed NaD1 and
NaD2 were similar to those of NaD1 and NaD2 purified from
plants, demonstrating that the recombinant expression system
produced defensins with the correct fold (Fig. 2A). On the basis of
the mean residue ellipticity at 222 nm ([]222), the helical content
(represented as the fractional helicity [fH]) for NaD1 and NaD2
was 16% and 6%, respectively (Fig. 2C). The CD-estimated
value for NaD1 was slightly lower than the actual helical content
(23%) in the nuclear magnetic resonance and X-ray structures
but consistent with it, considering that the CD data provide only
broad estimates. The CD spectra of all the loop swap proteins were
similar to the NaD1 spectrum, with fH values generally being in the
range of 16 to 18% (Fig. 2B). The largest differences were for the
CD spectra of L4A, with an fH value of 24%, and L6-L7, with an
fH value of 12%. L4A locates to the C-terminal cap region of the
single -helix in the cysteine-stabilized  motif structure of
NaD1, and hence, changes in this region can be expected to
directly affect helix propensity. Loop swaps with L6-L7 are ex-
Bleackley et al.
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pected to affect the C-terminal -strand. Despite the relatively
conservative substitutions (CLCTKPC in NaD1 versus CFC
TRPC in L6-L7), the helix propensity may have been impacted
indirectly because the -helix and C-terminal -strand are
tethered via two disulfide bonds (Fig. 1). L4B had a deeper
trough at 200 nm, indicating an increase in random coil sec-
ondary structure. Loop 4B forms one of the -strands, and
modification of this sequence may have affected formation of
the secondary structure.
Antifungal activity of NaD1-NaD2 loop swap chimeras
against F. oxysporum. The antifungal activity of the native floral
defensins and the recombinantly expressed defensins against F.
oxysporum was assessed. NaD1 (IC50, 1.5 	 0.25 M) was more
active than NaD2 (IC50, 8.3	 2.1M) (Fig. 3A and D). The IC50s
of recombinant NaD1 and NaD2 did not differ significantly from
those of the proteins isolated from plants, demonstrating that re-
combinant expression had no effect on the activity of these de-
fensins (data not shown). Swapping the L4A or L4B sequences of
NaD2 into the NaD1 backbone had no effect on the antifungal
activity of the defensin. However, replacement of L1A and L5 of
NaD1 with the corresponding NaD2 sequence decreased the
activity of the chimeric defensins. Increased activity was ob-
served when either L1B or L6-L7 of NaD2 was inserted into the
NaD1 framework in place of the native sequence. The loop 1B
swap produced the most active variant, which had an IC50 of
0.2	 0.04 M; in comparison, the IC50s were 1.5	 0.3 M for
NaD1 and 8.3	 2.1 M for NaD2. The least active variant was
L1A, which had an IC50 of 3.2 	 0.8 M (Fig. 3A and D).
Activity against amodel tumor cell line. Tumor cell killing by
native and recombinant defensins was determined by monitoring
propidium iodide (PI) uptake into the model monocytic lym-
phoma cell line U937. Recombinant NaD1 was much more effi-
cient at permeabilizing and killing U937 cells than recombinant
NaD2 (Fig. 3B). Replacement of either loop 4A or loops 6 and 7 of
NaD1 with the corresponding loops from NaD2 had no effect on
the tumor cell killing activity compared to that of NaD1. However,
substitution of loop 1A, 1B, 4B, or 5 generated chimeric defensins
with less antitumor cell activity than NaD1 (Fig. 3B and D). None
of the loop swap variants had increased activity relative to that of
NaD1 against U937 cells.
FIG 2 Circular dichroism of purified loop swap variants. (A) Recombinantly expressed and purified defensins (recombinant NaD1 and NaD2 [rD1 and rD2,
respectively]) have the same CD spectra as those purified from plants (natural NaD1 and NaD2 [nD1 and nD2, respectively]), indicating that the secondary
structure elements formed correctly. (B) Loop swap variants have CD spectra similar to those of the native sequences, demonstrating correct folding of the
proteins.(C) Percent helicity of native and recombinant NaD1 (rNaD1), recombinant NaD2 (rNaD2), and the loop swap variants. nNaD1 and nNaD2, natural
NaD1 and NaD2, respectively; MRW, mean residue weight; Fhelix, fractional helicity.
N. alata Defensin Loop Swaps
October 2016 Volume 60 Number 10 aac.asm.org 6305Antimicrobial Agents and Chemotherapy
 o
n
 D
ecem
ber 14, 2016 by UQ Library
http://aac.asm
.org/
D
ow
nloaded from
 
Permeabilization of PI(4,5)P2 liposomes.A calcein release as-
say was used to determine the permeabilizing activity of the native
defensins and the loop swap variants on bilayers of defined com-
position. Phosphatidylcholine (PC)-phosphatidyl (PE)-phospha-
tidylserine (PS)-phosphatidylinositol (PI) liposomes (molar ra-
tio, 52:30:10:8) were prepared with and without PI(4,5)P2 (4%)
and were loaded with calcein prior to incubation with each of the
defensins (1.25 M) for 10 min. Liposomes without PI(4,5)P2
were not permeabilized at a significant level by any of the defensins
tested (data not shown). When PI(4,5)P2 was present, NaD1 treat-
ment released the most calcein, whereas NaD2 had no activity
(Fig. 3C and D). There was no significant difference in permeabi-
lization of the PI(4,5)P2 liposomes by the L1B, L4A, and L6-L7
chimeras from that of NaD1. In contrast, the L4B chimera had
significantly less permeabilization activity than NaD1, and the L5
chimera had none.
Permeabilization of the F. oxysporum plasma membrane by
loop swap chimeras.Permeabilization of theF. oxysporumplasma
membrane was assayed by monitoring the uptake and fluores-
cence of the non-membrane-permeant dye SYTOX green over a
period of 180 min (Fig. 4). After a 20-min delay, there was a steady
increase in the fluorescence of the NaD1 (10 M)-treated hyphae
for the following 80 min. Hyphae incubated with 10 M NaD2
showed no increase in fluorescence over the 180-min time period,
indicating that this defensin did not permeabilize the plasma
membrane. The loop 5 chimera displayed permeabilization ki-
netics similar to those of NaD1. All the other loop swap chime-
ras had permeabilization profiles intermediate between those
of NaD1 and NaD2. L1A permeabilized more slowly than
FIG3 The antifungal, antitumor, and liposome-permeabilizing activities of the NaD1-NaD2 loop swap proteins. (A) The concentration of the NaD1-NaD2 loop
swap proteins required to inhibit the growth of the filamentous fungus F. oxysporum by 50% (IC50). The loop swap proteins L4B, L6-L7, and, particularly, L1B
had enhanced antifungal activity relative to that of NaD1, whereas L1A and L5 had decreased activity. (B) Activity of the NaD1-NaD2 loop swap proteins against
the U937 lymphoma cell line. Cell death was assessed by determination of the level of PI uptake into cells by flow cytometry after treatment with test protein at
10 M. All of the loop swap proteins, apart from L4A, L6, and L7, had less activity than recombinant NaD1. (C) The release of calcein from PC-PE-PS-PI-
PI(4,5)P2 liposomes by loop swap chimeras (1.25 M) after 10 min relative to that of the Triton X-100-treated control. NaD1 readily permeabilized liposomes,
while NaD2 had minimal permeabilization activity. All of the loop swap chimeras permeabilized liposomes with activities intermediate to those of NaD1 and
NaD2, except for L5, which did not permeabilize liposomes at all. Error bars are means 	 SEMs (n 
 3). Letters above the bars indicate overlapping 95%
confidence intervals. Values with the same letter are not significantly different.
FIG 4 Permeabilization of F. oxysporum hyphae by NaD1-NaD2 loop swap
variants. Permeabilization of F. oxysporum was assessed by monitoring the
uptake and fluorescence of the non-cell-permeant dye SYTOX green. All of the
loop swap variants permeabilized hyphae but did so to variable extents. NaD2
did not permeabilize hyphae at all. L5 displayed permeabilization kinetics
similar to those of NaD1, while the remaining loop swap variants all had lower
rates of permeabilization than NaD1. Data are representative of those from
three independent assays. RFU, relative fluorescence units.
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NaD1 or L5 but reached a similar plateau of fluorescence after
130 min. Initial permeabilization by L4A was at a rate similar to
that of NaD1 and L5, but the fluorescence reached a plateau at
a lower level. L1B and L4B displayed the slowest permeabiliza-
tion kinetics, but L4B fluorescence plateaued at the same lower
level as that of L4A, whereas L1B continued to permeabilize the
plasma membrane and achieved the same plateau as NaD1, L5,
and L1A.
Lipid binding. The specificity of lipid binding of the defensin
chimeras was examined using lipid strips (Fig. 5). Consistent with
the findings of previous studies, NaD1 interacted strongly with
PI(4,5)P2 and NaD2 interacted preferentially with phosphatidic
acid (PA) (10, 15) The chimeras L1B and L6-L7 had a similar
pattern of lipid binding to NaD1, whereas the pattern for L5 re-
sembled that for NaD2 with a preference for PA. The chimeras
L1A, L4A, and L4B bound to several lipids with no preference for
PA or PI(4,5)P2.
Activity of the L1B chimera against other pathogenic fungi.
As mentioned above, replacement of the loop 1B sequence of
NaD1 with the corresponding sequence from NaD2 led to a
substantial increase in activity against F. oxysporum compared
to that of the other chimeras and NaD1. The activity of L1B
chimera was thus tested against a range of other fungi (Table 1).
L1B was about 10 times more effective than NaD1 against F.
oxysporum and was also more active against the other agricul-
turally relevant pathogens: F. graminearum and C. graminicola.
L1B also inhibited the growth of the human pathogen A. flavus
with an IC50 of 3.5 M, whereas NaD1 had no effect at concen-
FIG 5 Lipid strip binding profiles of NaD1, NaD2, and the loop swap chimeras. The introduction of the different loop regions from NaD2 into NaD1
changed the lipid binding profiles of the protein. Binding of NaD1 and the loop-swapped proteins to PIP strips was detected by Western blotting with
polyclonal rabbit anti-NaD1 IgG, while NaD2 binding was detected with polyclonal rabbit anti-NaD2 IgG. Images are representative of those from two
separate experiments with different batches of strips. LPA, lysophosphatidic acid; LPC, lysophosphocholine; PI, phosphatidylinositol; pPI(3)P, phos-
phatidylinositol 3-phosphate; PI(4)P, phosphatidylinositol 4-phosphate; PI(5)P, phosphatidylinositol 5-phosphate; PE, phosphatidylethanolamine; PC,
phosphatidylcholine; S1P, sphingosine 1-phosphate; PI(3,4)P2, phosphatidylinositol 3,4-bisphosphate; PI(3,5)P2, phosphatidylinositol 3,5-bisphos-
phate; PI(4,5)P2, phosphatidylinositol 4,5-bisphosphate; PI(3,4,5)P3, phosphatidylinositol 3,4,5-trisphosphate; PA, phosphatidic acid; PS, phosphati-
dylserine; blue blank, lipid-negative control.
TABLE 1 IC50s of L1B loop swap chimera and NaD1 against other
pathogenic fungi
Fungal species
IC50 (M)
NaD1 L1B
Fusarium oxysporum 1.5	 0.25 0.16	 0.04
Fusarium graminearum 0.4	 0.3 0.28	 0.03
Colletotrichum graminicola 4.4	 0.1 2.0	 0.4
Aspergillus flavus 5310 10 3.5	 2.28
Aspergillus parasiticus 4467 4.5	 0.27 3.7	 1.17
Aspergillus niger 5181 2.1	 0.76 2.2	 1.22
Candida albicans DAY185 2.0	 0.07 2.0	 0.16
Cryptococcus neoformans H99 2.0	 0.15 1.6	 0.56
Cryptococcus gattii WM276 1.5	 0.59 1.6	 0.37
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trations up to 10 M. This enhanced activity relative to that of
NaD1 did not extend to the two other Aspergillus species tested.
Similarly, the sensitivity of the yeast pathogens C. albicans, C.
neoformans, and Cryptococcus gattii to L1B was unchanged com-
pared to that to NaD1.
Effect of PI(4,5)P2 bindingmolecule neomycin on antifungal
activity of NaD1. Neomycin is an aminoglycoside antibiotic that
binds to PI(4,5)P2 (23) and blocks the antitumor activity of NaD1
and other defensins that bind to PI(4,5)P2 (11, 17). To determine
whether neomycin could block the antifungal activity of NaD1, we
employed the model yeast S. cerevisiae, as the antifungal mecha-
nism of action of NaD1 is conserved between filamentous fungi
and yeast (21, 24). Yeast cells were treated with neomycin (0.1 to
10 mM), washed, and then treated with the antifungal peptides
NaD1, L5, and LL37. LL37 was included as a non-PI(4,5)P2 bind-
ing control. Survival was determined by plating serial dilutions of
the treated yeast cells on YPD plates and assessing colony forma-
tion (Fig. 6A). Neomycin did not protect the yeast cells against the
activity of any of the antifungal peptides.
Activity of NaD1 against S. cerevisiae strains with deletions
in genes that function in PI(4,5)P2 biosynthesis. The relation-
ship between PI(4,5)P2 binding and the antifungal activity of
NaD1 was examined further using a series of S. cerevisiae strains
that had deletions in the PI(4,5)P2 biosynthetic machinery (Fig.
7C). Three of the deleted genes, stt4,mss4, and pik1, are essential to
yeast viability; thus, the heterozygous diploid of each gene was
assayed for changes in NaD1 sensitivity compared with that of
wild-type diploid strain BY4743. The sensitivities of all other
FIG 6 Neomycin does not protect against the antifungal activity of NaD1, LL37, or L5. S. cerevisiae (BY4741) cells were treated with neomycin (0 to 10 mM) for
3 h, washed, and then treated with NaD1 (10 and 20M), LL37 (15 and 30M), or L5 (25 and 50M) for 1 h at 30°C. A 5-fold dilution series of each treatment
was plated on YPD agar and grown at 30°C for 2 days. Neomycin did not protect against any of the antifungal peptides tested. Data are representative of those
from three independent biological experiments.
FIG 7 Effect of NaD1 on the growth of S. cerevisiae mutants with gene knockouts in the PI(4,5)P2 biosynthesis pathway. (A) The growth of S. cerevisiae cells with
the heterozygous knockouts pik1, mss4, and stt4was similar to the growth of the parent cell line BY4743 (wild type [WT]) in the presence of NaD1 (0 to 2.5
M). (B) The growth inhibition of the S. cerevisiae nonessential PI(4,5)P2 biosynthesis knockouts lsb6, inp51, and inp52was similar to the growth inhibition
of the parent cell line BY4741 (wild type) in the presence of NaD1 (0 to 3 M). Growth was monitored by determination of the optical density at 595 nm over
24 h, and percent growth inhibition was plotted. Data are means	 SEMs (n
 4). (C) Functions of deleted genes and effects on PI(4,5)P2 levels. The numbers
in brackets represent reference citations (36–42).
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strains were compared with the sensitivity of wild-type haploid
strain BY4741. None of the deletion strains differed significantly
in their sensitivity to NaD1 (Fig. 7A and B).
DISCUSSION
The plant defensin NaD1 is produced in the flowers of the orna-
mental tobacco and functions to protect the reproductive tissues
from damage by fungal pathogens (25). It also efficiently kills
mammalian tumor cells at concentrations that have little effect on
normal cells (10). We prepared chimeras of NaD1 and a second
defensin, NaD2, that is produced in the same tissues as NaD1.
NaD2 is not as potent an antifungal molecule as NaD1 and has no
activity against tumor cells (Fig. 3). The overall aim of the work
was to identify the features of NaD1 that are responsible for its
potent activity against fungal and tumor cells with the objective of
using this knowledge to generate more active and specific de-
fensins for use in agriculture and medicine. These chimeras were
prepared by replacing, in turn, each of the seven surface loops on
NaD1 with the equivalent loops from NaD2. Apart from the chi-
meras with the loop 2 and 3 substitutions, all the loop swaps were
tolerated and the proteins were expressed and correctly folded,
allowing us to examine the relative importance of loops 1, 4, 5, 6,
and 7 to the antifungal and tumor cell activity of NaD1. The longer
loops, i.e., loops 1 and 4, were each divided into two sections,
loops 1A and 1B and loops 4A and 4B, respectively, whereas
shorter loops 6 and 7 were combined. Each of the loop swap chi-
meras was tested for activity against fungal (F. oxysporum) and
tumor (U937) cells. The established role for PI(4,5)P2 binding in
tumor cell killing by NaD1 led to the investigation of the interac-
tion between the loop swap variants and phospholipids, particu-
larly PI(4,5)P2.
Replacement of loop 1A, loop 1B, loop 4B, or loop 5 of NaD1
with the corresponding sequence of NaD2 decreased the activity
against tumor cells compared to that of NaD1. Apart from L1B,
each of these substitutions also had a major effect on PI(4,5)P2
binding and permeabilization of PI(4,5)P2 liposomes, consistent
with previous reports (10, 11) that PI(4,5)P2 binding and
oligomerization of the defensin are crucial for the tumor cell
killing activity of NaD1. The structure of NaD1 in complex
with PI(4,5)P2 revealed that 4 of the 6 residues from loop 5 (K36,
L37, L38, and R40) form the primary lipid binding domain of
NaD1 (10). Apart from R40, these residues are very different in
NaD2, explaining why NaD2 and the NaD1 chimera with loop 5
from NaD2 do not bind to PI(4,5)P2 on lipid strips and do not
permeabilize PI(4,5)P2-containing liposomes. The crystal struc-
ture also revealed that 3 of the 7 residues in loop 1A participate in
the formation of the NaD1 dimer that is needed to produce the
cationic grip structure that is essential for PI(4,5)P2 binding. Of
these three residues, R1, K4, and E6, the lysine at position 4 was the
most crucial (10). Lay and colleagues reported that replacement of
K4 with an alanine prevented dimer formation and increased the
IC50 5-fold against fungal cells (26). The lysine at position 4 also
participates in PI(4,5)P2 binding. Consequently, both K4 (in loop
1A) and R40 (in loop 5) have been described to be the key residues
involved in the formation of the oligomeric NaD1-PI(4,5)P2 com-
plex (10).
Another residue that interacts with PI(4,5)P2 is H33 (10),
which is 1 of the 4 residues in loop 4B. The chimera with the SGGD
sequence from NaD2 in place of the TDGH loop 4B sequence of
NaD1 had decreased activity compared with that of NaD1 against
tumor cells, was less effective at permeabilizing PI(4,5)P2 lipo-
somes, and bound less well to PI(4,5)P2 on lipid strips. These data
support the role of H33 in the PI(4,5)P2 interaction and the pre-
viously described role for D31 in the interaction between dimers
required to form the oligomer (10). Replacement of the 5 residues
in loop 4A of NaD1 (ISEKF) with the corresponding residues from
NaD2 (LTEGF) had no significant effect on the activity of the
chimera on tumor cells, fungal cells, or PI(4,5)P2 liposomes, prob-
ably because the sequences are similar. Residue E27, which is re-
quired for dimer formation, is present in both.
The loop 6 and 7 substitution encompassed four residues: F42,
which was changed to a leucine, and residues 44 to 46 (TKP),
which were changed to TRP. K45 participates in dimer formation,
but the conservative change to an arginine explains why the loop 6
and 7 substitution had no effect on activity against tumor cells,
PI(4,5)P2 binding, or liposome permeabilization.
There was a strong correlation between tumor cell killing ac-
tivity and the level of permeabilization of PI(4,5)P2 liposomes
across the set of loop swap variants, further highlighting the im-
portance of the NaD1-PI(4,5)P2 interaction for the antitumor ac-
tivity of NaD1 (Fig. 8). However, there was no correlation between
antifungal activity and the permeabilization of PI(4,5)P2 lipo-
somes, indicating that PI(4,5)P2 binding was not essential for the
antifungal activity of all of the defensin chimeras. To further assess
the role of PI(4,5)P2 binding in the antifungal activity of NaD1, we
determined whether neomycin has a protective effect in fungi sim-
ilar to that observed with NaD1 and the tomato defensin TPP3 in
tumor cells (10, 11). Neomycin did not protect yeast cells against
FIG 8 Correlation of lymphoma cell death, calcein release from PI(4,5)P2 liposomes, and IC50 against F. oxysporum. Linear regression analysis was performed
with the values for lymphoma death, calcein release, and IC50 against F. oxysporum from Fig. 3. The IC50 against F. oxysporum had R
2 values of 0.3653 and 0.3539
for lymphoma cell death and calcein release, respectively, indicating a poor correlation. Calcein release and lymphoma cell death had an R2 value of 0.8725,
indicating a strong correlation between the two values across the defensin chimeras.
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NaD1, LL37, or the L5 swap variant, confirming that PI(4,5)P2
binding is not essential for the antifungal activity of NaD1, as it is
for the antitumor activity. The lack of any significant difference in
the sensitivity of yeast cells with gene deletions that cause changes
in PI(4,5)P2 levels and the sensitivity of yeast cells without gene
deletions further supports the suggestion that the antifungal
mechanism of NaD1 involves more than binding to PI(4,5)P2.
That is not to say that PI(4,5)P2 binding does not have a role in
antifungal activity but does suggest that other mechanisms must
also be involved.
Many researchers have reported the importance of the loop 5
sequence for their antifungal defensins (reviewed in reference 27),
and the high sequence variability in this region led to the hypoth-
esis that they interact with different targets on fungal hyphae and,
hence, have different mechanisms of action. Replacement of loop
5 and loss of PI(4,5)P2 binding in the L5 chimera decreased the
IC50 against F. oxysporum by only 2-fold, but it abolished activity
against tumor cells. Indeed, even though the L5 chimera failed to
release calcein from the PI(4,5)P2 liposomes, it was as effective as
NaD1 in the permeabilization assays with F. oxysporum hyphae.
That is, it was able to enter fungal cells and disrupt the plasma
membrane in a PI(4,5)P2-independent way. Considering the in-
creased IC50 for L5, it was surprising that L5 displayed permeabi-
lization kinetics similar to those of NaD1. The permeabilization
assay was conducted using protein concentrations in excess of the
MIC and measures the rate of cell permeabilization by the peptide
as opposed to the effect on fungal growth. Thus, the difference in
observed IC50s between NaD1 and L5 must be related to differ-
ences in the antifungal mechanism of these proteins that are not
related to the rate of membrane permeabilization, such as a dif-
ference in affinity for a cell surface binding partner or ability to
enter the cytoplasm. NaD2, the defensin from which the loop 5
sequence in the L5 chimera was taken, binds to PA and does not
permeabilize the fungal membrane. Similarly, the IC50 of L5 was
more than 2-fold lower than that of NaD2, even though the two
defensins have very similar lipid binding profiles on PIP strips.
Hence, lipid binding is not the only determinant of antifungal
activity and sequences other than loop 5 must be contributing to
the improved activity of L5 compared to that of NaD2.
We hypothesize that NaD1 and, by extension, the loop swap
chimeras have a three-step mechanism of action on fungal cells.
The first interaction is with components of the fungal cell wall
(13), which it traverses before coming into contact with the
plasma membrane of fungal cells. It passes through the membrane
by a mechanism that has not been defined, and once it reaches the
cytoplasm it induces oxidative stress and permeabilizes the plasma
membrane (13, 21). The reactive oxygen species (ROS) alone may
be sufficient to initiate cell death. However, both ROS production
and an interaction of NaD1 with PI(4,5)P2 on the inner leaflet of
the membrane would compromise the membrane and ensure that
the cell cannot survive.
Knowing that PI(4,5)P2 binding, dimerization, and oligomer-
ization are all essential for the activity of NaD1 against tumor cells,
we asked why NaD2 had no effect on tumor cells. NaD2 did not
bind to PI(4,5)P2 on the lipid strips or the PI(4,5)P2-containing
liposomes. This was expected because NaD2 lacks most of the
amino acids that are crucial for PI(4,5)P2 binding, and we have
reported previously that it binds preferentially to PA (15).
As described for NaD1, loop 5 contains the residues that line
the cationic grip and define the lipid binding specificity for the
plant defensins. The loop 5 sequence of NaD2 is RGFRRR, which
is present in several other antifungal plant defensins (7). One of
these, MtDef4 from Medicago truncatula, has potent antifungal
activity and has been well studied (28). It shares 85% sequence
similarity with NaD2, and the loop 5 sequences are identical. Sa-
garam and colleagues (29) reported that, like NaD2, MtDef4 binds
to PA. Furthermore, amino acid substitutions in loop 5 impair PA
binding and abolish the ability of MtDef4 to enter and kill fungal
cells. Thus, PI(4,5)P2 binding is not required for the antifungal
activity of all plant defensins. Indeed, PI(4,5)P2 binding specificity
has been reported only for type II defensins from the Solanaceae
(15). Conversely, lipid binding alone is not sufficient for the anti-
fungal activity of plant defensins. A single-amino-acid variant
(Y38G) of RsAFP2 from radish bound to the cognate lipid gluco-
sylceramide at levels similar to those of the wild-type defensin but
had significantly impaired antifungal activity (30).
A common feature of antimicrobial peptides is that they carry
a positive net charge to facilitate interactions with negatively
charged microbial cell surfaces and the negatively charged lipid
head groups in the plasma membrane (1). Tumor cells, like mi-
crobial cells, have an anionic plasma membrane outer leaflet (31)
as well as a greater surface area and more fluid plasma membranes
than normal cells (32). The activity of plant antimicrobial peptides
against tumor cells could be the result of the increased suscepti-
bility of tumor cells to cationic membrane-disrupting peptides, as
they lack the protective capacity of a cell wall.
One of the most intriguing results from studies with the initial
loop swap variants was the increased activity observed for L1B,
L4A, and L6-L7 against F. oxysporum. NaD1 is more active as an
antifungal molecule than NaD2. Thus, it was expected that re-
placement of the loop regions of NaD1 with those of NaD2 would
be detrimental to antifungal activity, as was observed for antitu-
mor activity. L1B was the most active of the loop swap variants,
and although it retained PI(4,5)P2 binding activity in the PIP strip
assays, it displayed decreased permeabilization of PI(4,5)P2 lipo-
somes. Electrostatic interactions are a key component of the ac-
tivity of cationic peptides, including defensins, against fungi (24),
and L1B has an overall positive charge of 8, whereas that of
NaD1 is 6 (Fig. 1) and that of NaD2 is 5. Modeling of the
structure of the L1B chimera on the basis of the structure of NaD1
revealed that the two extra positively charged residues in loop 1B
would not prevent the formation of the dimers that are required
for antifungal activity (26), would not affect PI(4,5)P2 binding,
and are presented on the surface of the dimer (Fig. 9). The en-
hanced activity against fungal cells and decreased activity against
tumor cells suggest that L1B interacts with a fungus-specific target
and is not merely better at nonspecific disruption of negatively
charged phospholipids in the plasma membrane. This is sup-
ported by the observation that L1B exhibited delayed permeabili-
zation kinetics on fungal hyphae relative to those of NaD1 and was
less active than NaD1 in the calcein release assay. Thus, it is likely
that the enhanced activity of L1B is due an increased affinity for a
target within the fungal cell wall or with an intracellular target that
results in ROS production. L1B had enhanced activity against the
filamentous fungi F. graminearum, C. graminicola, A. flavus, and,
to a lesser extent, A. parasiticus. However, the activity of L1B
against yeasts and A. niger was similar to that of NaD1. The obser-
vation that the enhancement in antifungal activity varied widely
between fungal strains points to the potential involvement of the
fungal cell wall, which varies between fungal species (33), and/or
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to differences in the ability of the fungi to respond to cell wall,
osmotic, or oxidative stress (14, 21). Variations in cell wall com-
position have been proposed as an explanation for the different
effects that the defensin MtDef4 displays againstNeurospora crassa
and F. graminearum (34).
Similar loop swap experiments have been conducted with hu-
man-defensins to identify regions that produce the best antibac-
terial activity. Some chimeras had increased activity, whereas oth-
ers were less active (35), leading to the proposal that sequence
elements from different defensins make different contributions to
antimicrobial activity. Analogously, the different loop regions in a
plant defensin are likely to target different processes in the fungal
cell, explaining why different defensins have different mecha-
nisms of action. Swapping of loops between defensins could create
new combinations of these functions in a single molecule. This has
been proposed for dimers of short proline-rich antimicrobial pep-
tides that are active against bacteria. Fusion of the DNA-K binding
domain of pyrrhocoricin to the cell-penetrating region of droso-
cin increased activity against E. coli and allowed broader target
specificity (30). In the context of NaD1, it remains to be deter-
mined whether loop 1B from NaD2 conferred new antifungal ac-
tivity to the NaD1 backbone or enhanced the activity of the other
loops of NaD1.
It remains to be elucidated whether the combination of the
loop 1B sequence of NaD2 with other defensins would lead to an
increase in antifungal activity and, conversely, whether loop 1B
sequences from other class I defensins and/or other solanaceous
class II defensin scaffolds could also be used to enhance or
broaden the activity of antifungal plant defensins.
The constant threat from fungal pathogens has led plants to
evolve an arsenal of innate immunity molecules for protection
against devastating diseases. Plant defensins have a high degree of
sequence variability outside the invariant cysteine residues that
give them their characteristic structure. We propose that the loop
regions between the cysteine cross-links have evolved as modular
components that combine to form potent antifungal molecules.
Artificial combinations of these loops can both enhance and di-
minish antifungal activity. The increase in antifungal activity ob-
tained with some of these combinations suggests that nature has
not yet developed the most potent antifungal plant defensin. Fur-
ther shuffling of defensin sequences could produce antifungal
peptides that are more active than those presented here and could
lead to more desirable properties of this family of peptides for use
in the treatment of fungal disease.
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